Key result
New-onset hypertension before age 45 linked to ~126% greater CVD risk versus normotensive controls.
Why the study?
The relations of hypertension onset age with cardiovascular diseases and all-cause mortality remain inconclusive.
Does a younger age of hypertension onset increase the risk of cardiovascular diseases and all-cause mortality compared to older onset or normotension?
Population
19,887 matched case-control pairs from 71,245 participants free of hypertension and CVD in China
Comparison
New-onset hypertension across age groups vs age- and sex-matched controls
Design
Prospective matched case-control study nested in a cohort
Follow-up
Average 6.5 years
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“It is no surprise that hypertension beginning in young adults and early middle age results in a higher risk for cardiovascular disease and death than in older people. The challenge is to provide health literacy in elementary school and emphasize the seriousness of hypertension to young adults, particularly those with a family history of hypertension and CVD and social determinants that place them at highest risk.”
Early-onset hypertension may identify high-risk young adults for closer monitoring; leaves open whether earlier intervention improves outcomes.
Case-Control (n=71,245)
No
Does a younger age of hypertension onset increase the risk of cardiovascular diseases and all-cause mortality compared to older onset or normotension?
Effect estimate: HR 2.26 (95% CI 1.19-4.30)
Younger age of hypertension onset is associated with a substantially higher relative risk of cardiovascular disease and all-cause mortality, highlighting the importance of early blood pressure management.
Wang et al. (2020) conducted a case-control in Hypertension (n=71,245). New-onset hypertension vs. Matched normotensive controls was evaluated on Incident cardiovascular diseases (HR 2.26, 95% CI 1.19-4.30). New-onset hypertension was associated with increased risk of cardiovascular disease and mortality, with the strongest risk observed in patients with onset age <45 years (CVD HR 2.26; 95% CI 1.19-4.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: